Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gram positive infection in trauma patients: new strategies to decrease emerging Gram-positive resistance and

E Ginzburg1, N Namias, M Brown

  • 1Division of Trauma and Surgical Critical Care, Daughtry Family Department of Surgery (D-40), University of Miami School of Medicine, P.O. Box 016960, Miami, FL 33101, USA. eginzburg@miami.edu

International Journal of Antimicrobial Agents
|January 4, 2001
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel description of AT deficiency in hospitalized COVID-19 patients.

European review for medical and pharmacological sciences·2025
Same author

[Parkinson syndromes: aspects of social medical care].

Die Rehabilitation·2015
Same author

Through the 10-mm Looking Glass: Advances in Minimally Invasive Surgery in Trauma.

Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society·2014
Same author

Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma.

The British journal of surgery·2003
Same author

Evaluating blunt abdominal trauma with sonography: a cost analysis.

The American surgeon·2001
Same author

Prospective randomized trial of two wound management strategies for dirty abdominal wounds.

Annals of surgery·2001

Antibiotic resistance is a growing threat, especially in ICUs. A new strategy using short antibiotic pulses for methicillin-resistant Staphylococcus aureus (MRSA) infections may help combat resistance and reduce vancomycin-resistant enterococci (VRE).

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Antibiotic resistance, particularly from methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), poses a significant threat in healthcare settings.
  • Intensive care units (ICUs) experience high rates of these infections due to frequent antibiotic use.
  • Current MRSA treatment relies on vancomycin or teicoplanin, but overuse has led to VRE and the potential emergence of vancomycin-resistant S. aureus (VRSA).

Purpose of the Study:

  • To address the rising challenge of antibiotic resistance in Gram-positive infections within an ICU setting.
  • To propose and investigate an alternative antibiotic strategy for treating MRSA infections to mitigate resistance development.
  • To reduce the incidence of VRE and prevent the emergence of VRSA by restricting vancomycin use.

Related Experiment Videos

Main Methods:

  • Conducted a retrospective review of Gram-positive infections in a Level 1 Trauma Center ICU.
  • Analyzed resistance patterns of MRSA infections to determine the timeframe for resistance development.
  • Designed a novel treatment strategy involving sequential, short-term (5-7 day) antibiotic pulses for MRSA infections.

Main Results:

  • Analysis indicated that significant additional resistance in MRSA infections rarely develops within the initial 5 days of treatment.
  • The proposed strategy involves sequential antibiotic pulses to complete the full clinical course of MRSA infections.
  • Studies validating this pulsed-antibiotic approach are currently underway.

Conclusions:

  • Restricting vancomycin use and developing alternative strategies are crucial to combat VRE and prevent VRSA emergence.
  • A sequential, pulsed antibiotic regimen for MRSA infections is a promising alternative strategy.
  • Further clinical studies are needed to validate the efficacy and benefits of this novel treatment approach.